| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers T > Headlines for Talecris Biotherapeutics Inc. > News item |
S&P assigns Talecris loan BB-, B+
Standard & Poor's said it affirmed its loan and recovery ratings on Talecris Biotherapeutics Inc.'s senior secured first-lien term loan due 2013.
The agency added that the dollar amount of this loan was revised to $700 million from $1.2 billion.
The loan rating is BB-, one notch higher than the B+ corporate credit rating on Talecris, with a recovery rating of 1, S&P said.
In addition, the agency said it assigned its loan and recovery ratings to Talecris' $330 million second-lien term loan due 2014, adding that the second-lien loan rating is B+ with a recovery rating of 3.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.